Bing

NEW YORK (TheStreet) -- Boston Scientific Corp. stock was upgraded to "buy" from "neutral" with a price target of $20 at Goldman Sachs this morning. The firm remains constructive on MedTech going into the rest of the year and believes Boston Scientific …
Finanzen · 8/27/2015
NEW YORK ( TheStreet) -- Jim Cramer answered viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO - Get Report), Celgene (CELG - Get Report) and Boston Scientific (BSX - Get Report), and on …
The Street · ByJim Cramer · 1 day ago
Cramer
Boston Scientific (NYSE:BSX) Director John E. Abele purchased 200,000 shares of Boston Scientific stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average price of $17.48 per share, with a total value of $ ...
sleekmoney.com · 8/21/2015
More from Bing News
Separately, Canaccord Genuity cut their price objective on shares of Belo Sun Mining Corp from C$0.80 to C$0.70 and set a buy rating on the stock in a report on Saturday, July 18th. Belo Sun Mining Corp. (CVE:BSX), through its subsidiaries, is a gold ...
wkrb13.com · 1 day ago
Belo Sun
Boston Scientific (NYSE:BSX) Director John E. Abele purchased 200,000 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was purchased at an average cost of $16.77 per share, with a total value of $3,354,000.00.
Ticker Report · 8/25/2015
at $17 after 5,100 of its stock traded. Watlington Waterworks ended the week down 25 cents (1.2 per cent) at $20 after 1,000 shares were exchanged. The BSX Insurance Index slid 32.04 points (1.97 per cent) to close …
The Royal Gazette · 8/24/2015
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Boston Scientific Corp. (NYSE:BSX) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $14.1801 per share.
Market News Video · 8/24/2015
RSI
Last year, BSX stock faced an uphill battle as it hemorrhaged $4.9 billion into litigation expenses alone. Going forward, with the migraine known as the BSX-Guidant merger largely gone, Boston Scientific stock offers fine exposure to the healthcare sector.
Investor Place · 2/27/2015
John Abele, director emeritus at Boston Scientific ( BSX), bought 200,000 shares of the company's common stock on Aug. 19. At $17.48 per share, Abele paid a total of $3,496,000 for the new shares. IK-> The technicals for BSX ($16.60 down $0.26) are …
NASDAQ · 8/21/2015
Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), Boston Scientific (BSX), and on why September is a tough month on Wall Street. A viewer asked about Qorvo. Cramer …
11 Alive · 1 day ago

Boston Scientific

The Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used …
The Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Data from: Wikipedia · Freebase